Abiopharma

Clinical trial NCT07423598 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-15 → 2026-06-29 3. primary completion date: 2026-06-15 → 2026-06-29 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05983198 updates: 1. completion date: 2029-11-05 → 2031-03-04 2. primary completion date: 2026-11-19 → 2031-03-04

Clinical trial NCT06989775 updates: 1. completion date: 2031-11-01 → 2029-12-01 2. primary completion date: 2028-11-01 → 2027-02-01

Clinical trial NCT05627323 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2041-01-01 → 2026-05-29 3. primary completion date: 2026-12-01 → 2026-04-30 4. enrollment: 42 → 1 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07504601: start date: 2026-07-01 → 2026-07-02.

Clinical trial NCT07170644 updates: 1. completion date: 2029-10-31 → 2029-10-09 2. primary completion date: 2027-03-31 → 2027-05-28

Clinical trial NCT07354724: start date: 2026-05-01 → 2026-05-12.

Clinical trial NCT04387227: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT03682276 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-01 → 2026-03-12 3. primary completion date: 2023-09-01 → 2026-03-12 4. enrollment: 32 → 33 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06953934 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL